Showing 271-280 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Prohormone convertase activity in human T1D pancreas tissue slices | University of Florida | Denise Drotar | Cures | 01-March-2025 to 29-February-2028 | $264,895.00 |
| Cord Blood Proteomic Markers of Type 1 Diabetes Risk: Towards Validation in a Diverse Birth Cohort | University of Florida | Angelica Ahrens | Cures | 01-April-2026 to 31-March-2027 | $199,235.28 |
| Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation | University of Florida | Allison Bayer | Cures | 01-September-2023 to 31-March-2026 | $510,297.39 |
| Understanding Early Histopathological Changes in the Pancreas of those at Risk for Type 1 Diabetes Development | University of Florida | Alexandra Rippa | Cures | 01-March-2026 to 28-February-2029 | $237,690.00 |
| Engineering a novel Treg population to control autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-April-2025 to 31-December-2026 | $199,999.62 |
| Determining how NKG2D signaling drives autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-September-2023 to 31-August-2026 | $750,000.00 |
| Achieving immune protection in islet transplantation by combining peptide-loaded nanoparticles with conformal coating of islets | University of Kansas Medical Center Research Institute, Inc. | Hubert Tse | Cures | 01-April-2024 to 30-November-2026 | $599,998.25 |
| NKG2D Signaling as a Critical Modulator of Autoreactive CD8⁺ T Cell Differentiation and β Cell Destruction in Type 1 Diabetes | University of Kansas Medical Center Research Institute, Inc. | Ambika Dudhate | Cures | 01-March-2026 to 28-February-2029 | $274,010.00 |
| Enabling studies to advance intra-lymph node depots as a durable antigen-specific immunotherapy for T1D | University of Maryland | Christopher Jewell | Cures | 01-February-2023 to 31-January-2026 | $989,997.00 |
| Artificial Intelligence-driven redesign of beta cell regulatory logic for resilience to inflammation | University of Massachusetts Medical School | Rene Maehr | Cures | 01-April-2026 to 31-March-2027 | $199,999.88 |